FDA: Authorization of Emergency Use of a Medical Device During COVID-19; Availability

The Food and Drug Administration announces an Emergency Use Authorization for BioSynchronicity Corporation's C-Sync COVID –19 Antigen Test. The authorization is effective March 24, 2023.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news